Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HEXO Equities Warrants Exp 2 Apr 2024 T.HEXO.W.A

Hexo Corp. is a Canada-based consumer packaged goods cannabis company. The Company is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The Company serves the Canadian recreational market with a brand portfolio, including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market under HEXO medical cannabis in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes, and HEXO Plus high potency flower, exclusive to Quebec. Its brand Namaste is a recreational cannabis brand for mindful consumers.


TSX:HEXO.W.A - Post by User

Post by Duster340on Jun 09, 2023 11:54am
163 Views
Post# 35488576

Tilray CFO engages shareholders

Tilray CFO engages shareholders

Tilray Brands Inc (NASDAQ:TLRY)'s chief financial officer (CFO), Carl Merton recently took to Reddit in an Ask-Me-Anything (AMA) session, aiming to directly engage with shareholders and industry enthusiasts.

The move comes as Tilray faces questions about the cannabis market's volatility and its impact on the company's stock price.

Strengthening the Balance Sheet and Cash Position

During the AMA session, Merton, operating under the username "TilrayIR," addressed inquiries about Tilray's path to profitability and cost reduction strategies amidst various acquisitions.

Notably, Merton clarified that the recent refinancing deal was primarily focused on securing lower interest rates and bolstering the balance sheet, rather than covering previous losses, reported Green Market Report.

Merton also emphasized Tilray's commitment to strengthening the balance sheet and cash position by repaying debt and reinvesting in the company to drive global expansion. "We believe cash is king, and we remain focused on strengthening our balance sheet as well as our cash position by paying down a portion of debt and reinvesting in Tilray to further grow our global businesses," he stated.

Unlocking Value: Diverse Portfolio and Operational Optimization

Merton highlighted that Tilray's stock price fails to reflect the true value of its diverse portfolio. Notable achievements included the successful restructuring of Aphria Inc. (NASDAQ:APHA), expansion into multiple countries, and the company's ventures in the U.S. alcoholic beverage sector.

Additionally, Merton underscored Tilray's positive financial performance, with the company reporting 16 consecutive quarters of positive adjusted EBITDA—a feat unmatched among public cannabis companies under the leadership of CEO Irwin Simon.

He also emphasized the focus on optimizing operations, reducing costs, driving revenue, and generating free cash flow. Since the Aphria-Tilray merger, the company has already reduced costs by $122 million, with further cost reductions of $16 million planned, he said.

Addressing Concerns and Skepticism

During the session, Merton directly addressed concerns raised by participants. He clarified that recent actions were not part of a plan for a reverse stock split and dismissed claims that the refinancing deal and convertible note offer benefited short sellers, affirming that no shares were provided to cover their existing positions.

Merton also addressed executive compensation, emphasizing that CEO Simon does not receive exorbitant annual base salaries of $20 million or $30 million. Instead, the majority of Simon's and other top executives' compensation is tied to performance-based equity incentives.

Clearing the Air but Some Skepticism Remains: Merton concluded the AMA session with the hope that addressing questions and recurring themes would provide reassurance to investors and observers. However, despite his efforts, some participants and observers remained skeptical, seeking further clarity and pointing out potential discrepancies.

<< Previous
Bullboard Posts
Next >>